Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 1.96 Delayed Data As of Nov 26 |  -0.075 / -3.69%Today’s Change | 1.89 Today|||52-Week Range 14.79 | -81.96% Year-to-Date |
Latest ADVM News | Press Releases
No recent news for Adverum Biotechnologies Inc.
Today’s Trading
| Previous close | 2.03 |
| Today’s open | 1.98 |
| Day’s range | 1.90 - 1.99 |
| Volume | 43,065 |
| Average volume (3 months) | 2,029,255 |
| Market cap | $196.3M |
Data as of 1:00pm ET, 11/26/2021
Growth & Valuation
| Earnings growth (last year) | -37.19% |
| Earnings growth (this year) | -7.25% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SEELSeelos Therapeutics ... | -0.03 | -1.60% |
| CRMDCorMedix Inc | -0.13 | -2.49% |
| AQBAquaBounty Technolog... | -0.21 | -7.53% |
| SYBXSynlogic Inc | -0.04 | -1.52% |
Data as of 1:00pm ET, 11/26/2021
Financials
| Next reporting date | March 8, 2022 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$117.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
